Obigen Pharma Inc. (TPEX:7876)

Obigen Pharma Statistics

Total Valuation

Obigen Pharma has a market cap or net worth of TWD 3.97 billion. The enterprise value is 3.31 billion.

Market Cap	3.97B
Enterprise Value	3.31B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Obigen Pharma has 106.92 million shares outstanding.

Current Share Class	106.92M
Shares Outstanding	106.92M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	n/a
Float	106.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.37
P/TBV Ratio	3.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.07
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.62

Financial Position

The company has a current ratio of 22.42, with a Debt / Equity ratio of 0.06.

Current Ratio	22.42
Quick Ratio	22.32
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.57
Interest Coverage	-143.58

Financial Efficiency

Return on equity (ROE) is -15.21% and return on invested capital (ROIC) is -9.43%.

Return on Equity (ROE)	-15.21%
Return on Assets (ROA)	-9.35%
Return on Invested Capital (ROIC)	-9.43%
Return on Capital Employed (ROCE)	-16.38%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-5.18M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	37.49
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.53
Average Volume (20 Days)	154,604

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-287.74M
Pretax Income	-274.31M
Net Income	-274.31M
EBITDA	-191.13M
EBIT	-287.74M
Earnings Per Share (EPS)	-2.59

Balance Sheet

The company has 757.56 million in cash and 95.96 million in debt, with a net cash position of 661.60 million or 6.19 per share.

Cash & Cash Equivalents	757.56M
Total Debt	95.96M
Net Cash	661.60M
Net Cash Per Share	6.19
Equity (Book Value)	1.68B
Book Value Per Share	15.80
Working Capital	800.50M

Cash Flow

In the last 12 months, operating cash flow was -142.13 million and capital expenditures -26.63 million, giving a free cash flow of -168.76 million.

Operating Cash Flow	-142.13M
Capital Expenditures	-26.63M
Free Cash Flow	-168.76M
FCF Per Share	-1.58

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Obigen Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.91%
FCF Yield	-4.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1